VEGFA and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), BMS309403 curtailed tumour growth by downregulating key cell cycle genes (such as cyclin D1), VEGFA, and VEGFR expression, while inducing active caspase 3 [43].